Well Lead Medical Co Ltd
SSE:603309
Income Statement
Earnings Waterfall
Well Lead Medical Co Ltd
Revenue
|
1.3B
CNY
|
Cost of Revenue
|
-752.5m
CNY
|
Gross Profit
|
583.5m
CNY
|
Operating Expenses
|
-376.2m
CNY
|
Operating Income
|
207.4m
CNY
|
Other Expenses
|
-34.4m
CNY
|
Net Income
|
173m
CNY
|
Income Statement
Well Lead Medical Co Ltd
Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||||||||||||||||||||
Revenue |
496
N/A
|
504
+2%
|
506
+0%
|
533
+5%
|
549
+3%
|
553
+1%
|
533
-4%
|
523
-2%
|
515
-1%
|
531
+3%
|
576
+8%
|
599
+4%
|
630
+5%
|
644
+2%
|
658
+2%
|
682
+4%
|
746
+9%
|
809
+8%
|
883
+9%
|
957
+8%
|
994
+4%
|
957
-4%
|
1 089
+14%
|
1 125
+3%
|
1 131
+1%
|
1 194
+6%
|
1 055
-12%
|
1 054
0%
|
1 119
+6%
|
1 200
+7%
|
1 276
+6%
|
1 358
+6%
|
1 363
+0%
|
1 424
+4%
|
1 385
-3%
|
1 336
-4%
|
|
Gross Profit | |||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(318)
|
(329)
|
(337)
|
(360)
|
(365)
|
(373)
|
(351)
|
(341)
|
(323)
|
(340)
|
(367)
|
(390)
|
(416)
|
(435)
|
(453)
|
(468)
|
(484)
|
(520)
|
(540)
|
(561)
|
(558)
|
(543)
|
(605)
|
(620)
|
(637)
|
(685)
|
(621)
|
(628)
|
(647)
|
(706)
|
(748)
|
(792)
|
(785)
|
(812)
|
(779)
|
(752)
|
|
Gross Profit |
179
N/A
|
175
-2%
|
169
-3%
|
173
+2%
|
184
+6%
|
181
-2%
|
182
+1%
|
183
+0%
|
192
+5%
|
192
0%
|
209
+9%
|
209
N/A
|
214
+2%
|
209
-2%
|
205
-2%
|
214
+4%
|
262
+22%
|
289
+11%
|
343
+19%
|
396
+15%
|
436
+10%
|
413
-5%
|
484
+17%
|
505
+4%
|
494
-2%
|
510
+3%
|
434
-15%
|
425
-2%
|
472
+11%
|
494
+5%
|
528
+7%
|
566
+7%
|
578
+2%
|
612
+6%
|
606
-1%
|
584
-4%
|
|
Operating Income | |||||||||||||||||||||||||||||||||||||
Operating Expenses |
(89)
|
(87)
|
(90)
|
(95)
|
(106)
|
(104)
|
(107)
|
(112)
|
(125)
|
(123)
|
(128)
|
(134)
|
(141)
|
(140)
|
(149)
|
(161)
|
(197)
|
(205)
|
(226)
|
(247)
|
(278)
|
(273)
|
(281)
|
(286)
|
(266)
|
(280)
|
(278)
|
(284)
|
(315)
|
(321)
|
(344)
|
(361)
|
(373)
|
(393)
|
(388)
|
(376)
|
|
Selling, General & Administrative |
(81)
|
(86)
|
(89)
|
(94)
|
(96)
|
(103)
|
(106)
|
(111)
|
(111)
|
(122)
|
(129)
|
(133)
|
(124)
|
(131)
|
(139)
|
(149)
|
(172)
|
(194)
|
(214)
|
(233)
|
(227)
|
(220)
|
(212)
|
(213)
|
(199)
|
(221)
|
(229)
|
(235)
|
(246)
|
(267)
|
(278)
|
(286)
|
(274)
|
(294)
|
(288)
|
(277)
|
|
Research & Development |
(5)
|
0
|
0
|
0
|
(6)
|
0
|
0
|
0
|
(10)
|
0
|
0
|
(2)
|
(12)
|
(11)
|
0
|
(12)
|
(16)
|
(16)
|
(22)
|
(26)
|
(40)
|
(46)
|
(52)
|
(58)
|
(52)
|
(59)
|
(57)
|
(57)
|
(51)
|
(57)
|
(66)
|
(75)
|
(77)
|
(87)
|
(91)
|
(92)
|
|
Depreciation & Amortization |
(3)
|
0
|
0
|
0
|
(3)
|
0
|
0
|
0
|
(3)
|
0
|
0
|
0
|
(6)
|
0
|
0
|
0
|
(11)
|
0
|
0
|
0
|
(21)
|
0
|
0
|
0
|
(22)
|
0
|
0
|
0
|
(26)
|
0
|
0
|
0
|
(31)
|
0
|
0
|
0
|
|
Other Operating Expenses |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
1
|
2
|
1
|
(10)
|
(0)
|
1
|
5
|
10
|
10
|
10
|
(6)
|
(16)
|
(15)
|
7
|
(1)
|
8
|
8
|
8
|
3
|
(0)
|
(1)
|
9
|
(12)
|
(8)
|
(7)
|
|
Operating Income |
90
N/A
|
88
-2%
|
80
-9%
|
78
-3%
|
77
-1%
|
77
+0%
|
75
-3%
|
71
-5%
|
68
-5%
|
69
+2%
|
81
+17%
|
75
-7%
|
73
-2%
|
69
-6%
|
56
-19%
|
54
-4%
|
65
+21%
|
85
+31%
|
117
+38%
|
149
+27%
|
157
+6%
|
141
-10%
|
202
+44%
|
219
+8%
|
227
+4%
|
230
+1%
|
156
-32%
|
141
-9%
|
156
+11%
|
173
+10%
|
184
+6%
|
205
+11%
|
205
+0%
|
218
+7%
|
218
0%
|
207
-5%
|
|
Pre-Tax Income | |||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(4)
|
(2)
|
4
|
13
|
20
|
21
|
20
|
17
|
18
|
16
|
12
|
8
|
0
|
(5)
|
0
|
6
|
5
|
1
|
6
|
(1)
|
(13)
|
2
|
(11)
|
(15)
|
(17)
|
(19)
|
(20)
|
(15)
|
(10)
|
(10)
|
(1)
|
7
|
9
|
9
|
8
|
2
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(2)
|
(1)
|
(1)
|
(2)
|
(1)
|
0
|
0
|
1
|
0
|
2
|
0
|
0
|
0
|
(13)
|
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
(7)
|
0
|
0
|
(0)
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(3)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
|
Total Other Income |
1
|
1
|
3
|
2
|
3
|
3
|
4
|
9
|
10
|
11
|
8
|
3
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(2)
|
(2)
|
1
|
(6)
|
(5)
|
(5)
|
(5)
|
(2)
|
(3)
|
(4)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
Pre-Tax Income |
87
N/A
|
87
+0%
|
87
-1%
|
92
+7%
|
101
+9%
|
101
+0%
|
99
-2%
|
96
-3%
|
95
-1%
|
96
+1%
|
101
+5%
|
85
-16%
|
73
-14%
|
63
-14%
|
54
-14%
|
59
+10%
|
69
+16%
|
84
+23%
|
123
+46%
|
146
+19%
|
148
+1%
|
138
-7%
|
187
+36%
|
199
+6%
|
190
-4%
|
209
+10%
|
133
-36%
|
122
-8%
|
140
+15%
|
160
+14%
|
181
+13%
|
209
+16%
|
206
-2%
|
227
+10%
|
225
-1%
|
208
-8%
|
|
Net Income | |||||||||||||||||||||||||||||||||||||
Tax Provision |
(19)
|
(18)
|
(10)
|
(9)
|
(9)
|
(9)
|
(16)
|
(15)
|
(17)
|
(17)
|
(19)
|
(17)
|
(13)
|
(12)
|
(10)
|
(12)
|
(12)
|
(14)
|
(18)
|
(21)
|
(23)
|
(22)
|
(31)
|
(34)
|
(30)
|
(33)
|
(23)
|
(19)
|
(26)
|
(29)
|
(30)
|
(37)
|
(28)
|
(33)
|
(34)
|
(25)
|
|
Income from Continuing Operations |
68
|
69
|
77
|
84
|
91
|
92
|
83
|
81
|
79
|
79
|
82
|
68
|
60
|
50
|
43
|
47
|
56
|
70
|
105
|
125
|
125
|
116
|
155
|
165
|
160
|
175
|
110
|
103
|
115
|
131
|
151
|
173
|
178
|
194
|
191
|
183
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
3
|
4
|
5
|
7
|
8
|
9
|
9
|
7
|
2
|
(3)
|
(7)
|
(9)
|
(8)
|
(7)
|
(7)
|
(8)
|
(8)
|
(9)
|
(9)
|
(9)
|
(11)
|
(11)
|
(14)
|
(14)
|
(10)
|
|
Net Income (Common) |
68
N/A
|
69
+2%
|
77
+11%
|
84
+9%
|
91
+9%
|
92
+1%
|
84
-9%
|
82
-2%
|
79
-3%
|
80
+1%
|
84
+5%
|
71
-15%
|
65
-9%
|
56
-13%
|
50
-10%
|
55
+8%
|
65
+20%
|
79
+21%
|
112
+41%
|
128
+14%
|
121
-5%
|
109
-10%
|
147
+34%
|
157
+7%
|
153
-2%
|
168
+10%
|
103
-39%
|
95
-7%
|
106
+11%
|
122
+15%
|
142
+16%
|
162
+14%
|
167
+3%
|
180
+8%
|
176
-2%
|
173
-2%
|
|
EPS (Diluted) |
0.35
N/A
|
0.34
-3%
|
0.32
-6%
|
0.32
N/A
|
0.37
+16%
|
0.35
-5%
|
0.31
-11%
|
0.31
N/A
|
0.3
-3%
|
0.31
+3%
|
0.33
+6%
|
0.28
-15%
|
0.25
-11%
|
0.22
-12%
|
0.19
-14%
|
0.2
+5%
|
0.25
+25%
|
0.3
+20%
|
0.43
+43%
|
0.5
+16%
|
0.47
-6%
|
0.42
-11%
|
0.56
+33%
|
0.59
+5%
|
0.59
N/A
|
0.64
+8%
|
0.39
-39%
|
0.37
-5%
|
0.41
+11%
|
0.41
N/A
|
0.48
+17%
|
0.56
+17%
|
0.58
+4%
|
0.62
+7%
|
0.61
-2%
|
0.59
-3%
|